DMAC Operating Cash Flow Growth
Diamedica Therapeutics Inc · Operating Cash Flow Growth
DMAC Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-23.06%period ending
DMAC TTM Cash from Operations YoY % (-25.39% → -23.06%)
Year-over-year change
High-resolution chart · PNG
DMAC operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -23.059% | |
| -37.5592% | |
| -31.8937% | |
| -42.8285% | |
| -29.6749% | |
| -11.236% | |
| -17.877% | |
| -10.0215% | |
| -29.7455% | |
| -59.6287% | |
| -62.6966% | |
| -53.1042% | |
| -24.6199% | |
| -7.4829% | |
| 6.048% | |
| 7.3411% | |
| -3.9864% | |
| -12.424% | |
| -33.3914% | |
| -55.1407% | |
| -70.039% | |
| -17.5945% | |
| -0.9119% | |
| 12.1764% | |
| 29.2001% | |
| -12.8724% | |
| -59.7963% | |
| -92.1849% | |
| -172.8079% | |
| -99.0881% | |
| -46.0513% | |
| -13.2298% | |
| 19.4863% | |
| -16.1533% | |
| -29.0033% | |
| -101.1183% | |
| -251.8899% | |
| -137.0737% | |
| -121.3273% | |
| -82.6339% | |
| 21.6255% | |
| 51.0738% | |
| 63.6302% | |
| 71.9525% | |
| 65.1932% | |
| 38.1196% | |
| 31.7473% | |
| 37.1993% | |
| 36.7819% | |
| 28.3821% | |
| -0.3425% | |
| -22.7873% | |
| -76.7743% | |
| -92.6756% | |
| -59.5983% | |
| -95.1016% | |
| -175.0253% | |
| -26.6171% | |
| -44.5667% | |
| -16.3575% | |
| 54.2716% | |
| -37.613% | |
| -10.717% | |
| -32.3639% | |
| -71.0171% | |
| -2.7182% | |
| -46.3975% | |
| -12.685% | |
| -26.4016% | |
| -82.0466% | |
| -20.8516% | |
| -25.3878% |